NASDAQ:IOVA - Iovance Biotherapeutics, Inc.
$26.18
 $0.71
+2.79%
11:45AM EDT
2019-07-22
Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., incorporated on September 17, 2007, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program is an adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors, for the treatment of metastatic melanoma. As of December 31, 2016, the Company had an on-going Phase II clinical trial of its lead product candidate, LN-144, TIL for the treatment of metastatic melanoma. The Company is developing LN-145 to treat cervical and head and neck cancers. The Company is collaborating with the National Cancer Institute (NCI) to evaluate unmodified TIL in other solid tumor indications, such as ocular (uveal) melanoma, bladder, breast and lung cancer. The Company is also collaborating with Karolinska University Hospital to conduct clinical trials of TIL manufactured using a cytokine cocktail for expansion in pancreatic cancer and glioblastoma.The Company is collaborating with the NCI to evaluate TIL in combination with the checkpoint inhibitor, Keytruda (pembrolizumab). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  IOVA     avg for
industry  
  avg for
sector  
42 stocks weight:  416. 64   217. 37   399. 45  
42 stocks rank:  384. 00   1. 27 K 716. 99  
# analyst opinions:  8. 00   13. 21   13. 71  
mean recommendation:  1. 60   2. 10   2. 04  

quick ratio:  19. 88   5. 49   1. 88  
current ratio:  20. 09   5. 87   2. 36  

target price low:  24. 00   83. 44   114. 90  
target price avg:  33. 63   106. 20   137. 90  
target price high:  56. 00   132. 30   158. 97  
1-yr high:  25. 78   111. 86   142. 57  
last close:  25. 47   86. 79   125. 44  
50-day avg:  19. 79   86. 68   122. 63  
200-day avg:  12. 41   89. 22   121. 38  
1-yr low:  7. 51   69. 78   100. 51  
volume:  1. 20 M 2. 62 M 3. 43 M
50-day avg volume:  2. 22 M 3. 20 M 4. 16 M
200-day avg volume:  1. 51 M 2. 99 M 4. 75 M

1-day return:  -1. 20 % -1. 30 % -0. 99 %
this week return:  6. 52 % 0. 45 % -0. 20 %
12-wk return:  129. 46 % 0. 94 % 4. 84 %
52-wk return:  78. 41 % -1. 30 % 10. 55 %

enterprise value (EV):  2. 72 B 45. 10 B 122. 38 B
market cap:  3. 15 B 38. 96 B 108. 40 B
EBITDA:  -140. 37 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -19. 35   5. 38   11. 93  
total debt:  10. 44 M 10. 90 B 17. 48 B
debt/equity:  2. 40   57. 18   120. 05  
net income (common):  -134. 01 M 2. 07 B 4. 05 B

shares outstanding:  0. 00   538. 09 M 1. 24 B
shares:  99. 88 M 548. 00 M 1. 22 B
shares short:  13. 30 M 10. 98 M 11. 87 M
shares short prior month:  11. 58 M 9. 32 M 12. 05 M
short ratio:  5. 80   5. 60   3. 34  
short % of float:  11. 50 % 6. 48 % 2. 64 %
total cash/share:  3. 56   10. 98   9. 19  
total cash:  440. 02 M 5. 93 B 6. 10 B
free cash flow:  -65. 28 M 2. 92 B 4. 55 B
operating cash flow:  -112. 49 M 3. 80 B 5. 78 B

book value:  3. 52   13. 35   27. 45  
price/book:  7. 23   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -1. 25   2. 10   4. 23  
forward EPS:  -1. 40   3. 45   7. 10  
P/E:  -20. 34   1. 90   32. 10  
forward P/E:  -18. 19   6. 46   15. 47  
PE/G:  5. 32   0. 70   -0. 54  
growth:  -3. 82 % 265. 63 % 79. 11 %
earnings high:  -0. 18   0. 89   1. 68  
earnings avg:  -0. 29   0. 70   1. 57  
earnings low:  -0. 34   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -22. 99 % -2. 34 % 5. 28 %
return on equity:  -36. 84 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  2. 28   1. 27   0. 91  
sharpe (1yr):  1. 05   0. 16   0. 77  

held % insiders:  1. 14 % 6. 06 % 3. 29 %
held % institutions:  102. 66 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : IOVA
.    135.277 =       135.277 :: --> INITIAL WEIGHT <--
.    - 1.252 =       134.025 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.495 =       334.408 :: P/E factor
.    x 0.876 =       292.899 :: PE/G factor
.    x 1.638 =       479.705 :: beta factor
.    x 1.049 =       502.998 :: sharpe factor
.    x 3.598 =      1809.865 :: current ratio factor
.    x 1.026 =      1857.184 :: quick ratio factor
.    x 1.083 =      2010.923 :: short ratio factor
.    x 1.085 =      2181.294 :: price-to-book factor
.    x 1.021 =      2226.599 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      4722.156 :: sector+industry 1-year gains factor
.    x 1.009 =      4766.676 :: industry 12-weeks return factor
.    x 1.308 =      6234.282 :: industry 2-weeks return factor
.    x 1.709 =     10656.856 :: company one-year gains+dividend factor
.    x 3.603 =     38397.292 :: company 13 weeks' performance factor
.     x 3.03 =    116344.924 :: 5-day avg > 200-day avg
.    x 2.107 =    245087.965 :: 5-day avg > 50-day avg
.    x 1.595 =    390873.414 :: 50-day avg > 200-day avg
.    x 0.991 =    387297.924 :: "drift" penalty 4 days ago
.    / 2.074 =    186729.748 :: overall "drift" factor
.     x 0.78 =    145586.791 :: largest single-day jump factor
.        x 1 =    145586.791 :: volatility factor
.        x 1 =    145586.791 :: 42-day volatility factor
.     x 6.68 =    972469.121 :: notable returns + performance factor
.    x 4.293 =   4174578.845 :: performance vs s&p500 factor
.     x 3.19 =  13318382.893 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.898 =  11965683.132 :: forward EPS factor
.    x 0.963 =  11524063.159 :: forward P/E factor
.    x 1.185 =  13652701.667 :: industry recommendation factor
.    x 2.844 =   38832242.33 :: company recommendation factor
.    x 1.003 =  38939628.399 :: factor historical industry gain for week 29
.    x 0.963 =   37511896.77 :: target low factor
.    x 1.189 =  44589372.304 :: target mean factor
.    x 1.046 =  46639729.746 :: target high factor
.   x 10.259 =  478460728.38 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =       147.898 :: reduced for readability
.   + 258.89 =       406.788 :: add/subtract for investor sentiment
.    + 9.856 =       416.643 :: earnings report in 15 days
.                               --> FINAL WEIGHT <--
.                    416.643 :: FINAL WEIGHT for NASDAQ:IOVA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org